RTI Biologics, a provider of orthopedic and other biologic implants, reported third quarter revenues of $41.8 million, a 2 percent decrease from last year's third quarter report of 42.8 million, according to a company news release.
The Latest
There is little difference among the centrifuge systems currently available to separate blood for use in PRP injections, according to an article published in The American Journal of Sports Medicine.
Professional basketball players could be at a higher risk of injury from playing consecutive games and spending time on the road, according to an article published in Medill Reports Chicago.
Please enter and verify your e-mail address, then select the E-Weeklies you wish to subscribe to. Please allow one week for your subscription to begin.
Orthopedic and Spine Industry Leader to Know: Dr. Todd J. Albert of Philadelphia's Rothman Institute
Todd J. Albert, MD, spine surgeon and president of Rothman Institute in Philadelphia, is a clear leader in his field. He also serves as the James Edwards professor and chair of the orthopedic surgery department at Jefferson Medical College of…
"You can't manage what you don't measure" — words to live by, according to many ASC administrators. Aaron Murski, senior manager at VMG Health discusses 10 statistics every ASC should track and how frequently they should be tracked to ensure…
A recent Reuters analysis shows American patients aren’t seeking medical care at the rate they once did due to the economy, which has had an impact on a number of publicly traded healthcare firms, according to a Reuters report.
The Bonati Spine Institute of Hudson, Fla., which holds a patent for the Bonati Spine Procedures for minimally invasive laser spine surgery, is celebrating the company's 25th anniversary, according to a company news release.
Rob LaParade, MD, a physician with The Steadman Clinic in Vail, Colo., was recently featured in an article for Let's Play Hockey about treating quadriceps contusions for athletes.
Obesity influences the results of degenerative disorder treatments, according to a Spine Patient Outcomes Research Trial presented at the North American Spine Society annual meeting in Orlando, Fla.